Preeclampsia's Impact: How Maternal Hypertension Affects Premature Babies' Vision
"Discover the link between gestational hypertension and retinopathy of prematurity (ROP) in preterm infants. Understand the risks and what it means for your baby's eye health."
Premature births are on the rise, and with them comes an increased risk of retinopathy of prematurity (ROP), a leading cause of childhood blindness. While it's well-known that low birth weight and early gestational age are significant risk factors, recent studies suggest that other perinatal factors, particularly those affecting weight gain after birth, also play a crucial role.
One such factor is maternal gestational hypertension, including conditions like pre-eclampsia, eclampsia, and HELLP syndrome. These obstetric complications, affecting approximately 5% of pregnancies, can lead to severe maternal and fetal health issues. Studies show that pre-eclampsia may independently cause growth restriction in infants, as well as impacting levels of angiogenic factors.
This article explores the findings of a detailed study investigating the link between maternal gestational hypertension and the severity of ROP in preterm infants. We'll break down how these maternal conditions might interfere with an infant's retinal vascular development and what it could mean for their vision.
Preeclampsia and ROP Risk
Retinopathy of prematurity (ROP) is a vasoproliferative disease of the retina that occurs in premature infants. Preeclampsia and ROP are both associated with impaired angiogenesis, but studies examining their relationship have produced conflicting results. Large-cohort research has evaluated whether maternal gestational hypertension and preeclampsia influence ROP risk, while a separate cohort study specifically examined maternal preeclampsia and infant ROP development.
Classification and Examination
ROP diagnosis is performed by ophthalmoscopy, and disease outcomes can range from normal vision to blindness. The International Classification of Retinopathy of Prematurity was first developed in 1984, enabling comparison of clinical findings between centers and countries. Contemporary evaluation may compare binocular indirect ophthalmoscopy (BIO) with RetCam imaging for identifying ROP zones, stages, plus or pre-plus disease, and lesion extent, using the International Classification of Retinopathy of Prematurity, Third Edition (2021).
From RLF to ROP
Interest in classifying ROP developed near the end of the first epidemic, after a decade of uncertainty about the disease process and its evolution. In 1953, Reese and coworkers developed a standard system describing fundus findings of retrolental fibroplasia through direct ophthalmoscopy. Retrolental fibroplasia was later renamed retinopathy of prematurity as research established prematurity, or immaturity of the eye, as the primary cause. Later landmark trials included the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study, which showed that treating severe disease could reduce unfavorable visual outcomes.
Decoding Maternal Hypertension & ROP Risk: What the Research Reveals
A retrospective study, conducted at the University of North Carolina from 1996 to 2007, reviewed data from over 5,000 preterm infants. The study aimed to determine if maternal new-onset gestational hypertension (mHTN) was associated with a greater risk of severe retinopathy of prematurity (ROP).
- Infants with ROP were more likely to have mothers with mHTN and were typically younger and smaller at birth.
- At initial examination, infants of mothers with mHTN more frequently exhibited vascularization into the lower zones of the retina.
- However, at the examination when ROP was most severe, there was no direct association between mHTN and ROP stage.
- After adjusting for gestational age, infants born to mothers with mHTN were more likely to have ROP at the initial examination, but this association disappeared after adjusting for birth weight.
Conflicting Maternal Risk Evidence
A systematic review and meta-analysis examined neonatal and maternal risk factors for ROP and included studies from multiple countries and designs, including cohort and case-control research. Studies have reported conflicting findings about the association between preeclampsia and ROP. More recent research likewise notes that some studies reported an increased ROP risk associated with preeclampsia, underscoring that the maternal contribution remains unsettled.
Comparing Preterm Infant Groups
A comparative study assessed the incidence of ROP in preterm neonates born to mothers with preeclampsia and in neonates born to healthy mothers. The study framed preeclampsia as one of four leading causes of pregnancy complications, maternal-fetal mortality, and neonatal mortality. Its purpose was to compare ROP incidence between these two groups rather than assume that maternal preeclampsia has a uniform effect on every preterm infant.
What Does This Mean for Parents and Future Research?
While this study provides valuable insights, it's crucial to remember that the connection between maternal health and infant outcomes is complex. Conditions like pre-eclampsia introduce various factors that can impact a developing fetus.
Evidence of Elevated Risk
A cohort study reported that maternal preeclampsia was associated with a 2.5-fold increased risk of infants developing ROP. The reported association was also examined in a preterm cohort with very low birth weight. Separate research on preeclampsia and ophthalmic complications reported significant ophthalmic changes and emphasized the importance of close monitoring during pregnancy.
Training and Global Prevention
Future ROP care is being examined through research on training trends and the practice intentions of pediatric ophthalmology and retina fellows. ROP remains one of the leading causes of preventable childhood blindness, arising where neonatal survival gains meet uneven health-system capacity to protect visual outcomes. Forecasting work, including the Retinopathy of Prematurity Epidemiology Forecast 2035, projects future prevalence patterns using multiple variables and considers age, gender, and type as major determinants.
Uncertain Maternal Contribution
The relationship between gestational hypertension, preeclampsia, and ROP in preterm infants remains unclear. A large cohort database was used to study how maternal gestational hypertension and preeclampsia influenced the occurrence of ROP. The persistence of this uncertainty highlights the need to interpret maternal hypertension as one research factor within the broader clinical context of preterm birth.
Further research is needed to fully understand how maternal antiangiogenic factors, which are elevated in pre-eclampsia, cross the placenta and influence fetal retinal development. Understanding these mechanisms could lead to better preventative strategies and treatments for ROP.
Ultimately, this study underscores the importance of close monitoring and specialized care for preterm infants, especially those born to mothers with gestational hypertension. By staying informed and working closely with healthcare providers, parents can play an active role in safeguarding their child's vision.